Evotec SE nominates Dr. Wolfgang Hofmann to Supervisory Board, Globavend Holdings sees change in controlling shareholder and management, Royalty Management Holding Corporation continues annual dividend payments.

Scandium Canada Ltd. approves 2.1 million stock options at $0.22 each for its board members and management team through a shareholder-endorsed Share Option Plan, with Chairman Jeffrey Swinoga receiving 750,000 options.

Guardian Exploration Inc. appoints Ms. Elena Baranova to Advisory Board, Newron Pharmaceuticals elects new Board members, Lenzing Group re-elects Supervisory Board, and innoscripta SE approves dividend and relocation.

Shareholders approve all motions, including CHF 0.82 per share dividend. Jörn Nikolay re-elected as Chairman, with Patricia Lobinger as a new Board member. Visit SMG's investor relations website for further information.

Quenton Petersen appointed CEO at Massimo Group, focusing on growth in utility vehicles and AI features; Eric So becomes Interim CEO at Helus Pharma, emphasizing advancement of clinical pipeline. Justin Nimergood stresses importance of credibility in luxury real estate market.

Nagarro, InTiCa Systems, 10X Health, Energy Fuels, and Cicor Technologies announce key leadership appointments and approvals, while Culbertson Holdings receives a prestigious industry designation.

Ross R. Bhappu appointed as Energy Fuels Inc. CEO, Cicor Technologies Ltd. shareholders approve proposals. Culbertson Holdings named KeyCrew Verified Expert in Commercial Real Estate.

Culbertson Holdings, LLC, led by Culby Culbertson, is recognized as a KeyCrew Verified Expert, offering data-driven insights in commercial real estate capital markets with a focus on Texas.

Kudelski SA AGM saw Ms. Helene Beguin elected and Mr. Patrick Foetisch retire. Vallist's workspace approach focuses on member retention through quality partnerships, challenging traditional operators.

Dr. Nedim Cen resigns from Accentro Real Estate AG, replaced by Mr. Dariush Ghassemi-Moghadam. NRx Pharmaceuticals appoints Glenn Tyson as Chief Commercial Officer to prepare for product approvals and market launches.